Dr. Gulla is a board-certified urologist with fellowship training in endourology. She is a clinical assistant professor in the Stanford University School of Medicine Department of Urology.
For each patient, she develops a comprehensive, compassionate care plan customized to individual needs. Her goal is to help each patient achieve the best possible health and quality of life.
Dr. Gulla performs the complete spectrum of diagnostic and treatment procedures for urological conditions. She treats disorders including benign prostatic hyperplasia (BPH), blood in urine, kidney stones, male and female voiding dysfunction, neurogenic bladder, prostate cancer, and over active bladder.
She excels at ureteroscopy and cystoscopy (examination of the bladder and urinary tract with a scope), endourology (minimally invasive treatment of kidney stones), laser therapy, ultrasound-guided diagnosis and treatment, urodynamic testing, and other techniques.
To help advance her field, Dr. Gulla has conducted research. Among the topics she has investigated are voiding cystourethrogram (VCUG) testing in children for bladder and urethral abnormalities and for conditions that can lead to kidney infections.
She has presented her research findings at the national meeting of the American Urologic Association. She also has published papers in the Journal of the American College of Surgeons and elsewhere.
She is a member of the American Urologic Association.
- Benign Prostatic Hyperplasia
- Kidney Stones
- Male and Female Voiding Dysfunction
- Blood in Urine
Clinical Assistant Professor, Urology
Board Certification: American Board of Urology, Urology (2013)
Fellowship: Southmead Hospital Bristol (2011) United Kingdom
Residency: Dartmouth Hitchcock Urology Residency (2010) NH
Internship: Dartmouth Hitchcock General Surgery Residency (2006) NH
Medical Education: University of Vermont College of Medicine (2004) VT
Birth Trends and Pregnancy Complications among Women Urologists
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
2009; 208 (2): 293-297
As the number of women entering urology grows, so should discussions and awareness about pregnancy. To understand if urology training and practice potentially put women and their pregnancies at risk, we set out to assess the childbearing differences between the average American woman and the female urologist.A 114-item anonymous survey was sent to all 365 American board certified female urologists in 2007. Data concerning birth trends, pregnancy, assisted reproduction, and complications were analyzed. Findings were compared with 2004 CDC data.Two mailings yielded a 69% (n=243) response rate; average age was 43 years; 67.4% had biologic children (average 2.0 children). Women urologists were older by 7 to 8 years for all births. An assisted reproduction technology birth was nearly 10 times more likely. Pregnancy complications were high, with a prevalence greater than that in the lowest income brackets in the United States. The induction rate was above average; the rate of cesarean deliveries was similar, with only 21 elective procedures performed. Ninety-two percent of women urologists would choose to have the same number of children: 66% at the same point in their career; 16%, earlier; 4%, later; 15%, uncertain.Women urologists have children later in life, a smaller number, a higher induction rate, and a higher incidence of pregnancy complications. These are likely related to the older age at pregnancy, which certainly contributes to the higher number conceived by assisted reproduction technology. Cesarean delivery rates, which were expected to be higher, were similar. To avoid complications, childbearing should not be delayed, and residency programs and practice groups will need to develop programs that support the growing number of women urologists.
View details for DOI 10.1016/j.jamcollsurg.2008.10.012
View details for Web of Science ID 000263387500016
View details for PubMedID 19228542
Alterations in morning cortisol associated with PTSD in women with breast cancer
JOURNAL OF PSYCHOSOMATIC RESEARCH
2004; 56 (1): 13-15
Diagnosis and treatment of breast cancer can be a stressful experience, putting women at risk of posttraumatic stress disorder (PTSD). The current study investigated morning cortisol levels in newly diagnosed (i.e., within 6 months) breast cancer patients.Structured DSM-IV interviews determined current and past incidence of PTSD and major depressive disorder (MDD) in 71 women with Stage 0-3 breast cancer.Significantly decreased plasma cortisol was found in women meeting current or lifetime criteria for PTSD or past diagnosis of MDD.These results reinforce the importance for both psychological and physiological outcomes of a clinical evaluation of both current and past psychiatric status in newly diagnosed cancer patients.
View details for DOI 10.1016/S0022-3999(03)00561-0
View details for Web of Science ID 000220078500003
View details for PubMedID 14987959